Skip to main content
logo
Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China flag China · Delayed Price · Currency is CNY
21.90
-0.29 (-1.31%)
At close: Jun 11, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17
Pharmaceutical Manufacturing
896.64M808.19M---
Pharmaceutical Manufacturing Growth
10.94%----
Others
4.14M3.94M158.24M116.99M91.98M
Others Growth
4.98%-97.51%35.26%27.20%-
Gynecology
--362.67M352.79M379.84M
Gynecology Growth
--2.80%-7.12%-
Pediatrics
--99.68M86.85M104.76M
Pediatrics Growth
--14.77%-17.10%-
Cold
--160.62M130.87M99.21M
Cold Growth
--22.73%31.91%-
Unallocated Rent and lease
--3.99M4.07M3.91M
Unallocated Rent and lease Growth
---2.09%4.15%-
Total
900.77M812.13M785.19M691.57M679.70M
Total Growth
10.91%3.43%13.54%1.75%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17
East China
244.11M277.02M242.42M217.81M215.30M
East China Growth
-11.88%14.27%11.30%1.17%-
Southwest China
151.71M116.74M134.96M117.44M124.13M
Southwest China Growth
29.96%-13.50%14.92%-5.38%-
Northeast China
42.66M31.42M38.74M32.73M37.53M
Northeast China Growth
35.79%-18.89%18.34%-12.79%-
Northwestern China
39.13M34.02M38.49M36.46M35.82M
Northwestern China Growth
15.03%-11.63%5.57%1.78%-
North China
76.14M75.49M68.02M66.39M58.61M
North China Growth
0.86%10.99%2.45%13.28%-
Southern China
150.78M150.51M161.87M150.92M132.76M
Southern China Growth
0.18%-7.02%7.25%13.68%-
Central China
92.02M87.21M79.88M62.89M71.37M
Central China Growth
5.52%9.17%27.02%-11.88%-
Unallocated
104.21M39.73M20.81M6.92M4.18M
Unallocated Growth
162.31%90.88%200.73%65.41%-
Total
900.77M812.13M785.19M691.57M679.70M
Total Growth
10.91%3.43%13.54%1.75%-
Source: S&P Global Market Intelligence.